Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3. [electronic resource]
Producer: 20130725Description: 456-62 p. digitalISSN:- 1879-355X
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Carcinoma, Hepatocellular -- therapy
- Chemoradiotherapy -- methods
- Cyclin D1 -- antagonists & inhibitors
- Humans
- Inhibitor of Apoptosis Proteins -- antagonists & inhibitors
- Liver Neoplasms -- therapy
- Myeloid Cell Leukemia Sequence 1 Protein
- Neoplasm Proteins -- antagonists & inhibitors
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- pharmacology
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- RNA Interference
- Radiation Tolerance -- drug effects
- STAT3 Transcription Factor -- antagonists & inhibitors
- Sorafenib
- Survivin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.